Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Oxcarbazepine and carbamazepine: expected and unexpected differences and similarities.

Literature DB >> 17520080

Oxcarbazepine and carbamazepine: expected and unexpected differences and similarities.

Bassel W Abou-Khalil.

Abstract

Entities: Chemical

Year: 2007 PMID： 17520080 PMCID： PMC1874328 DOI： 10.1111/j.1535-7511.2007.00176.x

Source DB: PubMed Journal: Epilepsy Curr ISSN： 1535-7511 Impact factor: 7.500

× No keyword cloud information.

12 in total

1. Effect of carbamezapine and valproic acid on bone mineral density, IGF-I and IGFBP-3.

Authors: Sefer Kumandas; Esad Koklu; Hakan Gümüs; Selmin Koklu; Selim Kurtoglu; Musa Karakukcu; Mehmet Keskin
Journal: J Pediatr Endocrinol Metab Date: 2006-04 Impact factor: 1.634

2. Adverse effects of antiepileptic drugs on bone mineral density.

Authors: Arzu Babayigit; Eray Dirik; Ece Bober; Handan Cakmakci
Journal: Pediatr Neurol Date: 2006-09 Impact factor: 3.372

3. Serum sex hormone levels after replacing carbamazepine with oxcarbazepine.

Authors: J I Isojärvi; A J Pakarinen; A Rautio; O Pelkonen; V V Myllylä
Journal: Eur J Clin Pharmacol Date: 1995 Impact factor: 2.953

4. Effects of carbamazepine and oxcarbazepine on the reproductive endocrine function in women with epilepsy.

Authors: Eeva Löfgren; Juha S Tapanainen; Riitta Koivunen; Arto Pakarinen; Jouko I T Isojärvi
Journal: Epilepsia Date: 2006-09 Impact factor: 5.864

5. Reproductive effects of valproate, carbamazepine, and oxcarbazepine in men with epilepsy.

Authors: J Rättyä; J Turkka; A J Pakarinen; M Knip; M A Kotila; O Lukkarinen; V V Myllylä; J I Isojärvi
Journal: Neurology Date: 2001-01-09 Impact factor: 9.910

6. The regulation of serum sodium after replacing carbamazepine with oxcarbazepine.

Authors: J I Isojärvi; U E Huuskonen; A J Pakarinen; O Vuolteenaho; V V Myllylä
Journal: Epilepsia Date: 2001-06 Impact factor: 5.864

7. Serum hormones in male epileptic patients receiving anticonvulsant medication.

Authors: J I Isojärvi; A J Pakarinen; P J Ylipalosaari; V V Myllylä
Journal: Arch Neurol Date: 1990-06

Review 8. What is the evidence that oxcarbazepine and carbamazepine are distinctly different antiepileptic drugs?

Authors: Dieter Schmidt; Christian E Elger
Journal: Epilepsy Behav Date: 2004-10 Impact factor: 2.937

9. Differential effects of antiepileptic drugs on sexual function and reproductive hormones in men with epilepsy: interim analysis of a comparison between lamotrigine and enzyme-inducing antiepileptic drugs.

Authors: Andrew G Herzog; Frank W Drislane; Donald L Schomer; Page B Pennell; Edward B Bromfield; Kevin M Kelly; Erin L Farina; Cheryl A Frye
Journal: Epilepsia Date: 2004-07 Impact factor: 5.864

Oxcarbazepine and carbamazepine: expected and unexpected differences and similarities.

1. Effect of carbamezapine and valproic acid on bone mineral density, IGF-I and IGFBP-3.

2. Adverse effects of antiepileptic drugs on bone mineral density.

3. Serum sex hormone levels after replacing carbamazepine with oxcarbazepine.

4. Effects of carbamazepine and oxcarbazepine on the reproductive endocrine function in women with epilepsy.

5. Reproductive effects of valproate, carbamazepine, and oxcarbazepine in men with epilepsy.

6. The regulation of serum sodium after replacing carbamazepine with oxcarbazepine.

7. Serum hormones in male epileptic patients receiving anticonvulsant medication.

Review 8. What is the evidence that oxcarbazepine and carbamazepine are distinctly different antiepileptic drugs?

9. Differential effects of antiepileptic drugs on sexual function and reproductive hormones in men with epilepsy: interim analysis of a comparison between lamotrigine and enzyme-inducing antiepileptic drugs.

10. Thyroid and myocardial function after replacement of carbamazepine by oxcarbazepine.

1. The safety and tolerability of newer antiepileptic drugs in children and adolescents.

Review 2. Pharmacogenomic Biomarkers and Their Applications in Psychiatry.

3. Trigeminal neuralgia: An overview from pathophysiology to pharmacological treatments.

Review 4. Nanotherapeutics for Nose-to-Brain Drug Delivery: An Approach to Bypass the Blood Brain Barrier.